Single-cell sequencing combined with spatial transcriptomics reveals that the IRF7 gene in M1 macrophages inhibits the occurrence of pancreatic cancer by regulating lipid metabolism-related mechanisms

Ting Zhan , Yanli Zou , Zheng Han , XiaoRong Tian , Mengge Chen , Jiaxi Liu , Xiulin Yang , Qingxi Zhu , Meng Liu , Wei Chen , Mingtao Chen , Xiaodong Huang , Jie Tan , Weijie Liu , Xia Tian

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (8) : e1799

PDF
Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (8) :e1799 DOI: 10.1002/ctm2.1799
RESEARCH ARTICLE
Single-cell sequencing combined with spatial transcriptomics reveals that the IRF7 gene in M1 macrophages inhibits the occurrence of pancreatic cancer by regulating lipid metabolism-related mechanisms
Author information +
History +
PDF

Abstract

Aim: The main focus of this study is to explore the molecular mechanism of IRF7 regulation on RPS18 transcription in M1-type macrophages in pancreatic adenocarcinoma (PAAD) tissue, as well as the transfer of RPS18 by IRF7 via exosomes to PAAD cells and the regulation of ILF3 expression.

Methods: By utilising single-cell RNA sequencing (scRNA-seq) data and spatial transcriptomics (ST) data from the Gene Expression Omnibus database, we identified distinct cell types with significant expression differences in PAAD tissue. Among these cell types, we identified those closely associated with lipid metabolism. The differentially expressed genes within these cell types were analysed, and target genes relevant to prognosis were identified. Flow cytometry was employed to assess the expression levels of target genes in M1 and M2 macrophages. Cell lines with target gene knockout were constructed using CRISPR/Cas9 editing technology, and cell lines with target gene knockdown and overexpression were established using lentiviral vectors. Additionally, a co-culture model of exosomes derived from M1 macrophages with PAAD cells was developed. The impact of M1 macrophage-derived exosomes on the lipid metabolism of PAAD cells in the model was evaluated through metabolomics analysis. The effects of M1 macrophage-derived exosomes on the viability, proliferation, division, migration and apoptosis of PAAD cells were assessed using MTT assay, flow cytometry, EdU assay, wound healing assay, Transwell assay and TUNEL staining. Furthermore, a mouse PAAD orthotopic implantation model was established, and bioluminescence imaging was utilised to assess the influence of M1 macrophage-derived exosomes on the intratumoural formation capacity of PAAD cells, as well as measuring tumour weight and volume. The expression of proliferation-associated proteins in tumour tissues was examined using immunohistochemistry.

Results: Through combined analysis of scRNA-seq and ST technologies, we discovered a close association between M1 macrophages in PAAD samples and lipid metabolism signals, as well as a negative correlation between M1 macrophages and cancer cells. The construction of a prognostic risk score model identified RPS18 and IRF7 as two prognostically relevant genes in M1 macrophages, exhibiting negative and positive correlations, respectively. Mechanistically, it was found that IRF7 in M1 macrophages can inhibit the transcription of RPS18, reducing the transfer of RPS18 to PAAD cells via exosomes, consequently affecting the expression of ILF3 in PAAD cells. IRF7/RPS18 in M1 macrophages can also suppress lipid metabolism, cell viability, proliferation, migration, invasion and intratumoural formation capacity of PAAD cells, while promoting cell apoptosis.

Conclusion: Overexpression of IRF7 in M1 macrophages may inhibit RPS18 transcription, reduce the transfer of RPS18 from M1 macrophage-derived exosomes to PAAD cells, thereby suppressing ILF3 expression in PAAD cells, inhibiting the lipid metabolism pathway, and curtailing the viability, proliferation, migration, invasion of PAAD cells, as well as enhancing cell apoptosis, ultimately inhibiting tumour formation in PAAD cells in vivo. Targeting IRF7/RPS18 in M1 macrophages could represent a promising immunotherapeutic approach for PAAD in the future.

Keywords

exosomes / ILF3 / IRF7 / M1 macrophages / pancreatic adenocarcinoma / RPS18 / scRNA-seq / spatial transcriptomics

Cite this article

Download citation ▾
Ting Zhan, Yanli Zou, Zheng Han, XiaoRong Tian, Mengge Chen, Jiaxi Liu, Xiulin Yang, Qingxi Zhu, Meng Liu, Wei Chen, Mingtao Chen, Xiaodong Huang, Jie Tan, Weijie Liu, Xia Tian. Single-cell sequencing combined with spatial transcriptomics reveals that the IRF7 gene in M1 macrophages inhibits the occurrence of pancreatic cancer by regulating lipid metabolism-related mechanisms. Clinical and Translational Medicine, 2024, 14(8): e1799 DOI:10.1002/ctm2.1799

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Wang W, Xing H, Huang C, Pan H, Li D. Identification of pancreatic cancer type related factors by weighted gene co-expression network analysis. Med Oncol. 2020;37:33.

[2]

Sun Y, Wang X, Yao L, He R, Man C, Fan Y. Construction and validation of a RARRES3-based prognostic signature related to the specific immune microenvironment of pancreatic cancer. Front Oncol. 2024;14:1246308.

[3]

Du Y, Xin Z, Liu T, Xu P, Mao F, Yao J. Overexpressed CA12 has prognostic value in pancreatic cancer and promotes tumor cell apoptosis via NF-kappaB signaling. J Cancer Res Clin Oncol. 2021;147:1557-1564.

[4]

Zhao Z, Ju Q, Ji J, Li Y, Zhao Y. N6-methyladenosine methylation regulator RBM15 is a potential prognostic biomarker and promotes cell proliferation in pancreatic adenocarcinoma. Front Mol Biosci. 2022;9:842833.

[5]

Hua S, Gao J, Li T, et al. The promoting effects of hsa_circ_0050102 in pancreatic cancer and the molecular mechanism by targeting miR-1182/NPSR1. Carcinogenesis. 2021;42:471-480.

[6]

Wang J, Zhang Y, Wang Q, Wang L, Zhang P. Study on the potential molecular mechanism of Xihuang Pill in the treatment of pancreatic cancer based on network pharmacology and bioinformatics. Evid Based Complement Alternat Med. 2022;2022:4651432.

[7]

Wang H, Wu Z, Liu Y, et al. A novel strategy to reveal clinical advantages and molecular mechanism of aidi injection in the treatment of pancreatic cancer based on network meta-analysis and network pharmacology. J Ethnopharmacol. 2022;285:114852.

[8]

Rao L, Zhao SK, Wen C, et al. Activating macrophage-mediated cancer immunotherapy by genetically edited nanoparticles. Adv Mater. 2020;32:e2004853.

[9]

Gelbach PE, Finley SD. Ensemble-based genome-scale modeling predicts metabolic differences between macrophage subtypes in colorectal cancer. Biorxiv. 2023.

[10]

Wang Q, Bergholz JS, Ding L, et al. STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer. Nat Commun. 2022;13:3022.

[11]

Wang X, Wang C, Guan J, Chen B, Xu L, Chen C. Progress of breast cancer basic research in China. Int J Biol Sci. 2021;17:2069-2079.

[12]

Wu SZ, Al-Eryani G, Roden DL, et al. A single-cell and spatially resolved atlas of human breast cancers. Nat Genet. 2021;53:1334-1347.

[13]

Heinrich MA, Heinrich L, Ankone MJK, Vergauwen B, Prakash J. Endotoxin contamination alters macrophage-cancer cell interaction and therapeutic efficacy in pre-clinical 3D in vitro models. Biomater Adv. 2023;144:213220.

[14]

Mao X, Xu J, Wang W, et al. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer. 2021;20:131.

[15]

van Niel G, Carter DRF, Clayton A, Lambert DW, Raposo G, Vader P. Challenges and directions in studying cell-cell communication by extracellular vesicles. Nat Rev Mol Cell Biol. 2022;23:369-382.

[16]

Shen L, Zhan X. Mitochondrial dysfunction pathway alterations offer potential biomarkers and therapeutic targets for ovarian cancer. Oxid Med Cell Longev. 2022;2022:5634724.

[17]

Klein AP. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nat Rev Gastroenterol Hepatol. 2021;18:493-502.

[18]

Wood LD, Canto MI, Jaffee EM, Simeone DM. Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment. Gastroenterology. 2022;163:386-402.e381.

[19]

Yin X, Xu R, Song J, et al. Lipid metabolism in pancreatic cancer: emerging roles and potential targets. Cancer Commun. 2022;42:1234-1256.

[20]

Zhao Z, Liu W. Pancreatic cancer: a review of risk factors, diagnosis, and treatment. Technol Cancer Res Treat. 2020;19:1533033820962117.

[21]

Terado T, Kim CJ, Ushio A, et al. Cryptotanshinone suppresses tumorigenesis by inhibiting lipogenesis and promoting reactive oxygen species production in KRAS activated pancreatic cancer cells. Int J Oncol. 2022;61(3):108.

[22]

Jin HR, Wang J, Wang ZJ, et al. Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics. J Hematol Oncol. 2023;16:103.

[23]

Moncada R, Barkley D, Wagner F, et al. Integrating microarray-based spatial transcriptomics and single-cell RNA-seq reveals tissue architecture in pancreatic ductal adenocarcinomas. Nat Biotechnol. 2020;38:333-342.

[24]

Ye C, Zhu J, Wang J, et al. Single-cell and spatial transcriptomics reveal the fibrosis-related immune landscape of biliary atresia. Clin Transl Med. 2022;12:e1070.

[25]

Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19:1423-1437.

[26]

Sun Y, Ren D, Yang C, et al. TRIM15 promotes the invasion and metastasis of pancreatic cancer cells by mediating APOA1 ubiquitination and degradation. Biochim Biophys Acta Mol Basis Dis. 2021;1867:166213.

[27]

Visweswaran M, Arfuso F, Warrier S, Dharmarajan A. Aberrant lipid metabolism as an emerging therapeutic strategy to target cancer stem cells. Stem Cells. 2020;38:6-14.

[28]

Biancur DE, Kimmelman AC. The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance. Biochim Biophys Acta Rev Cancer. 2018;1870:67-75.

[29]

Cheng C, Geng F, Cheng X, Guo D. Lipid metabolism reprogramming and its potential targets in cancer. Cancer Commun. 2018;38:27.

[30]

Zhang X, Fan L, Wu J, et al. Macrophage p38alpha promotes nutritional steatohepatitis through M1 polarization. J Hepatol. 2019;71:163-174.

[31]

Li Z, Geng M, Ye X, et al. IRF7 inhibits the Warburg effect via transcriptional suppression of PKM2 in osteosarcoma. Int J Biol Sci. 2022;18:30-42.

[32]

Kamerkar S, Leng C, Burenkova O, et al. Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity. Sci Adv. 2022;8:eabj7002.

[33]

Jiang H, Zhou L, Shen N, et al. M1 macrophage-derived exosomes and their key molecule lncRNA HOTTIP suppress head and neck squamous cell carcinoma progression by upregulating the TLR5/NF-kappaB pathway. Cell Death Dis. 2022;13:183.

[34]

Yin Z, Ma T, Lin Y, et al. IL-6/STAT3 pathway intermediates M1/M2 macrophage polarization during the development of hepatocellular carcinoma. J Cell Biochem. 2018;119:9419-9432.

[35]

Qi J, Sun H, Zhang Y, et al. Single-cell and spatial analysis reveal interaction of FAP(+) fibroblasts and SPP1(+) macrophages in colorectal cancer. Nat Commun. 2022;13:1742.

[36]

Tirumurugaan KG, Pawar RM, Dhinakar Raj G, Thangavelu A, Hammond JA, Parida S. RNAseq reveals the contribution of interferon stimulated genes to the increased host defense and decreased PPR viral replication in cattle. Viruses. 2020;12(4):463.

[37]

Gaidt MM, Morrow A, Fairgrieve MR, Karr JP, Yosef N, Vance RE. Self-guarding of MORC3 enables virulence factor-triggered immunity. Nature. 2021;600:138-142.

[38]

Lu F, Wang R, Xia L, et al. Regulation of IFN-Is by MEF2D promotes inflammatory homeostasis in microglia. J Inflamm Res. 2021;14:2851-2863.

[39]

Zhou H, Tang YD, Zheng C. Revisiting IRF1-mediated antiviral innate immunity. Cytokine Growth Factor Rev. 2022;64:1-6.

[40]

Ma W, Huang G, Wang Z, Wang L, Gao Q. IRF7: role and regulation in immunity and autoimmunity. Front Immunol. 2023;14:1236923.

[41]

Ambite I, Butler D, Wan MLY, et al. Molecular determinants of disease severity in urinary tract infection. Nat Rev Urol. 2021;18:468-486.

[42]

Ning S, Pagano JS, Barber GN. IRF7: activation, regulation, modification and function. Genes Immun. 2011;12:399-414.

[43]

Qing F, Liu Z. Interferon regulatory factor 7 in inflammation, cancer and infection. Front Immunol. 2023;14:1190841.

[44]

Siska PJ, Rathmell JC. Metabolic signaling drives IFN-gamma. Cell Metab. 2016;24:651-652.

[45]

Wang SW, Gao C, Zheng YM, et al. Current applications and future perspective of CRISPR/Cas9 gene editing in cancer. Mol Cancer. 2022;21:57.

[46]

Qiao Q, Liu X, Yang T, et al. Nanomedicine for acute respiratory distress syndrome: the latest application, targeting strategy, and rational design. Acta Pharm Sin B. 2021;11:3060-3091.

[47]

Hwang WL, Jagadeesh KA, Guo JA, et al. Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment. Nat Genet. 2022;54:1178-1191.

[48]

Shankland SJ, Wang Y, Shaw AS, Vaughan JC, Pippin JW, Wessely O. Podocyte aging: why and how getting old matters. J Am Soc Nephrol. 2021;32:2697-2713.

[49]

Wu TD, Madireddi S, de Almeida PE, et al. Peripheral T cell expansion predicts tumour infiltration and clinical response. Nature. 2020;579:274-278.

[50]

Venkatanarayan A, Liang J, Yen I, et al. CRAF dimerization with ARAF regulates KRAS-driven tumor growth. Cell Rep. 2022;38:110351.

[51]

Ji C. The effect of miR-496 on eIF3h in lung invasive adenocarcinoma. Acta Biochim Pol. 2021;68:627-632.

[52]

Yu DC, Liu J, Chen J, et al. GGPPS1 predicts the biological character of hepatocellular carcinoma in patients with cirrhosis. BMC Cancer. 2014;14:248.

[53]

Steele NG, Carpenter ES, Kemp SB, et al. Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer. Nat Cancer. 2020;1:1097-1112.

[54]

Carpenter ES, Elhossiny AM, Kadiyala P, et al. Analysis of donor pancreata defines the transcriptomic signature and microenvironment of early neoplastic lesions. Cancer Discov. 2023;13:1324-1345.

[55]

Keefe F, Monzon-Sandoval J, Rosser AE, Webber C, Li M. Single-cell transcriptomics reveals conserved regulatory networks in human and mouse interneuron development. Int J Mol Sci. 2023;24(9):8122.

[56]

Olaniru OE, Kadolsky U, Kannambath S, et al. Single-cell transcriptomic and spatial landscapes of the developing human pancreas. Cell Metab. 2023;35:184-199.e185.

[57]

Shao X, Liao J, Lu X, Xue R, Ai N, Fan X. scCATCH: automatic annotation on cell types of clusters from single-cell RNA sequencing data. iScience. 2020;23:100882.

[58]

Zhu X, Zou W, Meng X, et al. Elaiophylin inhibits tumorigenesis of human uveal melanoma by suppressing mitophagy and inducing oxidative stress via modulating SIRT1/FoxO3a signaling. Front Oncol. 2022;12:788496.

[59]

Wang P, Wang H, Huang Q, et al. Exosomes from M1-polarized macrophages enhance paclitaxel antitumor activity by activating macrophages-mediated inflammation. Theranostics. 2019;9:1714-1727.

[60]

Nakamura R, Bing R, Gartling GJ, Branski RC. Macrophages alter inflammatory and fibrotic gene expression in human vocal fold fibroblasts. Exp Cell Res. 2022;419:113301.

[61]

Trajkovic K, Hsu C, Chiantia S, et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science. 2008;319:1244-1247.

[62]

Lu T, Li J, Qian S, Cao H, Ning C, Liu X. Enhanced osteogenic and selective antibacterial activities on micro-/nano-structured carbon fiber reinforced polyetheretherketone. J Mater Chem B. 2016;4:2944-2953.

[63]

Rong D, Sun G, Zheng Z, et al. MGP promotes CD8(+) T cell exhaustion by activating the NF-kappaB pathway leading to liver metastasis of colorectal cancer. Int J Biol Sci. 2022;18:2345-2361.

[64]

He W, Zhang H, Han F, et al. CD155T/TIGIT signaling regulates CD8(+) T-cell metabolism and promotes tumor progression in human gastric cancer. Cancer Res. 2017;77:6375-6388.

[65]

Jiang T, Zhao D, Zheng Z, Li Z. Sigma-1 receptor alleviates airway inflammation and airway remodeling through AMPK/CXCR4 signal pathway. Inflammation. 2022;45:1298-1312.

[66]

Zeng X, Yao B, Liu J, et al. The SMARCA4(R1157W) mutation facilitates chromatin remodeling and confers PRMT1/SMARCA4 inhibitors sensitivity in colorectal cancer. NPJ Precis Oncol. 2023;7:28.

[67]

Nishiyama T, Zhang Y, Cui M, et al. Precise genomic editing of pathogenic mutations in RBM20 rescues dilated cardiomyopathy. Sci Transl Med. 2022;14:eade1633.

[68]

Zhang Z, Wang J, Chen Y, et al. Activin a promotes myofibroblast differentiation of endometrial mesenchymal stem cells via STAT3-dependent Smad/CTGF pathway. Cell Commun Signal. 2019;17:45.

[69]

Wang Y, Zhou Z, Liu Y, Wang Z, Kang Y. Inhibition of Smad3 promotes the healing of rotator cuff injury in a rat model. J Orthop Res. 2021;39:204-218.

[70]

Ni H, Qin H, Sun C, et al. MiR-375 reduces the stemness of gastric cancer cells through triggering ferroptosis. Stem Cell Res Ther. 2021;12:325.

[71]

Shi L, Chen H, Qin YY, Gan TQ, Wei KL. Clinical and biologic roles of PDGFRA in papillary thyroid cancer: a study based on immunohistochemical and in vitro analyses. Int J Clin Exp Pathol. 2020;13:1094-1107.

[72]

Wang Z, Ma XF, Wan CC, Zhang L, Wang JB. Effect of negative regulation of LncRNA XIST to MiR-196b on the biological behavior of acute myeloid leukemia cells KG1a. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2022;30:1318-1323.

[73]

Ayuk SM, Abrahamse H, Houreld NN. The role of photobiomodulation on gene expression of cell adhesion molecules in diabetic wounded fibroblasts in vitro. J Photochem Photobiol B. 2016;161:368-374.

[74]

Wu Q, Yi X. Down-regulation of long noncoding RNA MALAT1 protects hippocampal neurons against excessive autophagy and apoptosis via the PI3K/Akt signaling pathway in rats with epilepsy. J Mol Neurosci. 2018;65:234-245.

[75]

Mao Q, Liang XL, Zhang CL, Pang YH, Lu YX. LncRNA KLF3-AS1 in human mesenchymal stem cell-derived exosomes ameliorates pyroptosis of cardiomyocytes and myocardial infarction through miR-138-5p/Sirt1 axis. Stem Cell Res Ther. 2019;10:393.

[76]

Yang L, Shao X, Jia S, Zhang Q, Jin Z. Interleukin-35 dampens CD8(+) T cells activity in patients with non-viral hepatitis-related hepatocellular carcinoma. Front Immunol. 2019;10:1032.

[77]

Jiang G, Shi L, Zheng X, et al. Androgen receptor affects the response to immune checkpoint therapy by suppressing PD-L1 in hepatocellular carcinoma. Aging. 2020;12:11466-11484.

[78]

Tao X, Du R, Guo S, et al. PGE(2)-EP3 axis promotes brown adipose tissue formation through stabilization of WTAP RNA methyltransferase. EMBO J. 2022;41:e110439.

[79]

Song HS, Choi MY, Ko MS, et al. Competitive inhibition of cytosolic Ca2+-dependent phospholipase A2 by acteoside in RBL-2H3 cells. Arch Pharm Res. 2012;35:905-910.

[80]

Hu Y, Gong C, Li Z, et al. Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification. Mol Cancer. 2022;21:34.

[81]

Zhan J, Yuan J, Liu J, Zhang F, Yu F, Wang Y. Metabolomics analysis of mycelial exudates provides insights into fungal antagonists of Armillaria. Mycology. 2023;14:264-274.

[82]

Petrenko V, Sinturel F, Loizides-Mangold U, et al. Type 2 diabetes disrupts circadian orchestration of lipid metabolism and membrane fluidity in human pancreatic islets. PLoS Biol. 2022;20:e3001725.

[83]

Hannich JT, Loizides-Mangold U, Sinturel F, et al. Ether lipids, sphingolipids and toxic 1-deoxyceramides as hallmarks for lean and obese type 2 diabetic patients. Acta Physiol. 2021;232:e13610.

[84]

Pietilainen KH, Sysi-Aho M, Rissanen A, et al. Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects–a monozygotic twin study. PLoS One. 2007;2:e218.

[85]

Wang Y, Yang H, Su X, et al. SREBP2 promotes the viability, proliferation, and migration and inhibits apoptosis in TGF-beta1-induced airway smooth muscle cells by regulating TLR2/NF-kappaB/NFATc1/ABCA1 regulatory network. Bioengineered. 2022;13:3137-3147.

[86]

Ning H, Albersen M, Lin G, Lue TF, Lin CS. Effects of EdU labeling on mesenchymal stem cells. Cytotherapy. 2013;15:57-63.

[87]

Cheung EC, DeNicola GM, Nixon C, et al. Dynamic ROS control by TIGAR regulates the initiation and progression of pancreatic cancer. Cancer Cell. 2020;37:168-182. e164.

[88]

Li H, Liang J, Wang J, et al. Mex3a promotes oncogenesis through the RAP1/MAPK signaling pathway in colorectal cancer and is inhibited by hsa-miR-6887-3p. Cancer Commun. 2021;41:472-491.

[89]

Wu Y, Zhu B, Yan Y, et al. Long non-coding RNA SNHG1 stimulates ovarian cancer progression by modulating expression of miR-454 and ZEB1. Mol Oncol. 2021;15:1584-1596.

[90]

Ye C, Qi W, Dai S, et al. microRNA-223 promotes autophagy to aggravate lung ischemia-reperfusion injury by inhibiting the expression of transcription factor HIF2alpha. Am J Physiol Lung Cell Mol Physiol. 2020;319:L1-L10.

[91]

Liu S, Shen S, Yan Y, et al. Triiodothyronine (T3) promotes brown fat hyperplasia via thyroid hormone receptor alpha mediated adipocyte progenitor cell proliferation. Nat Commun. 2022;13:3394.

[92]

Zhang DX, Dang XTT, Vu LT, et al. alphavbeta1 integrin is enriched in extracellular vesicles of metastatic breast cancer cells: a mechanism mediated by galectin-3. J Extracell Vesicles. 2022;11:e12234.

[93]

Zeng FM, Li YW, Deng ZH, et al. SARS-CoV-2 spike spurs intestinal inflammation via VEGF production in enterocytes. EMBO Mol Med. 2022;14:e14844.

[94]

Gong L, Tang Y, An R, Lin M, Chen L, Du J. RTN1-C mediates cerebral ischemia/reperfusion injury via ER stress and mitochondria-associated apoptosis pathways. Cell Death Dis. 2017;8:e3080.

[95]

Cui Y, Wang D, Xie M. Tumor-derived extracellular vesicles promote activation of carcinoma-associated fibroblasts and facilitate invasion and metastasis of ovarian cancer by carrying miR-630. Front Cell Dev Biol. 2021;9:652322.

[96]

Xiong H, Ye J, Xie K, Hu W, Xu N, Yang H. Exosomal IL-8 derived from lung cancer and colon cancer cells induced adipocyte atrophy via NF-kappaB signaling pathway. Lipids Health Dis. 2022;21:147.

[97]

Li W, Liu D, Xu J, et al. Astrocyte-derived TNF-alpha-activated platelets promote cerebral ischemia/reperfusion injury by regulating the RIP1/RIP3/AKT signaling pathway. Mol Neurobiol. 2022;59:5734-5749.

[98]

Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinf. 2008;9:559.

[99]

Zhang J, Zheng Y, Wang Y, et al. YAP1 alleviates sepsis-induced acute lung injury via inhibiting ferritinophagy-mediated ferroptosis. Front Immunol. 2022;13:884362.

[100]

Shankara Narayanan JS, Vicente DA, Ray P, et al. Pressure-enabled delivery of gemcitabine in an orthotopic pancreatic cancer mouse model. Surgery. 2020;168:448-456.

[101]

Zhao F, Wang M, Li S, et al. DACH1 inhibits SNAI1-mediated epithelial-mesenchymal transition and represses breast carcinoma metastasis. Oncogenesis. 2015;4:e143.

[102]

Zhou S, Meng F, Du S, et al. Bifunctional iRGD-anti-CD3 enhances antitumor potency of T cells by facilitating tumor infiltration and T-cell activation. J Immunother Cancer. 2021;9(5):e001925.

[103]

Bian J, Cai F, Chen H, et al. Modulation of local overactive inflammation via injectable hydrogel microspheres. Nano Lett. 2021;21:2690-2698.

[104]

Cheng R, Chen Y, Zhou H, Wang B, Du Q, Chen Y. B7-H3 expression and its correlation with clinicopathologic features, angiogenesis, and prognosis in intrahepatic cholangiocarcinoma. APMIS. 2018;126:396-402.

[105]

Cong P, Wu T, Huang X, et al. Identification of the role and clinical prognostic value of target genes of m6A RNA methylation regulators in glioma. Front Cell Dev Biol. 2021;9:709022.

[106]

Morris R, Loftus A, Friedmann Y, Parker P, Pallister I. Intra-pelvic pressure changes after pelvic fracture: a cadaveric study quantifying the effect of a pelvic binder and limb bandaging over a bolster. Injury. 2017;48:833-840.

RIGHTS & PERMISSIONS

2024 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.

PDF

418

Accesses

0

Citation

Detail

Sections
Recommended

/